In a preclinical study, the BBB penetration properties and the cerebral distribution of two other PI3K inhibitors (GDC-0941 and GNE-317) were examined in U87 MG and GS2 intracranial GBM xenograft mouse models. Here, PIK3CA is linked to glioblastoma.